Cargando…
Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo)
Haemorrhagic cystitis (HC) is a recognised complication in patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). This study evaluates the incidence and severity of HC in patients undergoing allogeneic HSCT during hospitalisation and within the first 100 days following trans...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998658/ https://www.ncbi.nlm.nih.gov/pubmed/24834115 http://dx.doi.org/10.3332/ecancer.2014.420 |
_version_ | 1782313406263459840 |
---|---|
author | Gargiulo, G Orlando, L Alberani, F Crabu, G Di Maio, A Duranti, L Errico, A Liptrott, S Pitrone, R Santarone, S Soliman, C Trunfio, A Selleri, C Bruno, B Mammoliti, S Pane, F |
author_facet | Gargiulo, G Orlando, L Alberani, F Crabu, G Di Maio, A Duranti, L Errico, A Liptrott, S Pitrone, R Santarone, S Soliman, C Trunfio, A Selleri, C Bruno, B Mammoliti, S Pane, F |
author_sort | Gargiulo, G |
collection | PubMed |
description | Haemorrhagic cystitis (HC) is a recognised complication in patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). This study evaluates the incidence and severity of HC in patients undergoing allogeneic HSCT during hospitalisation and within the first 100 days following transplant, looking at the use of prophylaxis, management of HC, outcomes at 100 days post transplant, and to identify any correlations between development of HC and the different conditioning regimens for transplant or HC prevention methods used. RESULTS: Four hundred and fifty patients (412 adult and 38 paediatric) were enrolled in this prospective, multicentre, and observational study. HC was observed in 55 patients (12.2%) of which 8/38 were paediatric (21% of total paediatric sample) and 47/412 adults (11.4% of total adult sample). HC was observed primarily in the non-related HSCT group (45/55; 81.8%, p= 0.001) compared to sibling and myeloablative transplant protocols (48/55; 87.3%; p= 0.008) and with respect to reduced intensity conditioning regimens (7/55;12.7%). In 33 patients with HC (60%), BK virus was isolated in urine samples, a potential co-factor in the pathogenesis of HC. The median day of HC presentation was 23 days post HSCT infusion, with a mean duration of 20 days. The most frequent therapeutic treatments were placement of a bladder catheter (31/55; 56%) and continuous bladder irrigation (40/55; 73%). The range of variables in terms of conditioning regimens and so on, makes analysis difficult. CONCLUSIONS: This multi-centre national study reported similar incidence rates of HC to those in the literature. Evidence-based guidelines for prophylaxis and management are required in transplant centres. Further research is required to look at both prophylactic and therapeutic interventions, which also consider toxicity of newer conditioning regimens. |
format | Online Article Text |
id | pubmed-3998658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Cancer Intelligence |
record_format | MEDLINE/PubMed |
spelling | pubmed-39986582014-05-15 Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo) Gargiulo, G Orlando, L Alberani, F Crabu, G Di Maio, A Duranti, L Errico, A Liptrott, S Pitrone, R Santarone, S Soliman, C Trunfio, A Selleri, C Bruno, B Mammoliti, S Pane, F Ecancermedicalscience Review Haemorrhagic cystitis (HC) is a recognised complication in patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). This study evaluates the incidence and severity of HC in patients undergoing allogeneic HSCT during hospitalisation and within the first 100 days following transplant, looking at the use of prophylaxis, management of HC, outcomes at 100 days post transplant, and to identify any correlations between development of HC and the different conditioning regimens for transplant or HC prevention methods used. RESULTS: Four hundred and fifty patients (412 adult and 38 paediatric) were enrolled in this prospective, multicentre, and observational study. HC was observed in 55 patients (12.2%) of which 8/38 were paediatric (21% of total paediatric sample) and 47/412 adults (11.4% of total adult sample). HC was observed primarily in the non-related HSCT group (45/55; 81.8%, p= 0.001) compared to sibling and myeloablative transplant protocols (48/55; 87.3%; p= 0.008) and with respect to reduced intensity conditioning regimens (7/55;12.7%). In 33 patients with HC (60%), BK virus was isolated in urine samples, a potential co-factor in the pathogenesis of HC. The median day of HC presentation was 23 days post HSCT infusion, with a mean duration of 20 days. The most frequent therapeutic treatments were placement of a bladder catheter (31/55; 56%) and continuous bladder irrigation (40/55; 73%). The range of variables in terms of conditioning regimens and so on, makes analysis difficult. CONCLUSIONS: This multi-centre national study reported similar incidence rates of HC to those in the literature. Evidence-based guidelines for prophylaxis and management are required in transplant centres. Further research is required to look at both prophylactic and therapeutic interventions, which also consider toxicity of newer conditioning regimens. Cancer Intelligence 2014-04-10 /pmc/articles/PMC3998658/ /pubmed/24834115 http://dx.doi.org/10.3332/ecancer.2014.420 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Gargiulo, G Orlando, L Alberani, F Crabu, G Di Maio, A Duranti, L Errico, A Liptrott, S Pitrone, R Santarone, S Soliman, C Trunfio, A Selleri, C Bruno, B Mammoliti, S Pane, F Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo) |
title | Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo) |
title_full | Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo) |
title_fullStr | Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo) |
title_full_unstemmed | Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo) |
title_short | Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo) |
title_sort | haemorrhagic cystitis in haematopoietic stem cell transplantation (hsct): a prospective observational study of incidence and management in hsct centres within the gitmo network (gruppo italiano trapianto midollo osseo) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998658/ https://www.ncbi.nlm.nih.gov/pubmed/24834115 http://dx.doi.org/10.3332/ecancer.2014.420 |
work_keys_str_mv | AT gargiulog haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT orlandol haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT alberanif haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT crabug haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT dimaioa haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT durantil haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT erricoa haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT liptrotts haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT pitroner haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT santarones haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT solimanc haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT trunfioa haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT selleric haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT brunob haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT mammolitis haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo AT panef haemorrhagiccystitisinhaematopoieticstemcelltransplantationhsctaprospectiveobservationalstudyofincidenceandmanagementinhsctcentreswithinthegitmonetworkgruppoitalianotrapiantomidolloosseo |